南方医科大学，是一所位于中华人民共和国广东省的公立医科大学，前身为1951年8月创建于黑龙江省齐齐哈尔市的东北军区军医学校，后历经改制、更名和搬迁，于1970年2月迁至广东省广州市，1975年2月更名为中国人民解放军第一军医大学，2004年8月移交广东省人民政府，并更名为南方医科大学。

During the past decade, Southern Medical University conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.2% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 1 clinical trials were completed. i.e. 4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Medical University" #1 sponsor was "Nanfang Hospital of Southern Medical University" with 6 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Zhujiang Hospital" with 4 trials sponsored, "Shenzhen Geno-Immune Medical Institute" with 3 trials sponsored and "Chen Chunlin" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Medical University" #1 collaborator was "Shenzhen Children's Hospital" with 4 trials as a collaborator, "Zhujiang Hospital" with 3 trials as a collaborator, "Jiangmen Maternity and Child Health Care Hospital" with 2 trials as a collaborator, "Shenzhen Hospital of Southern Medical University" with 2 trials as a collaborator and "Shenzhen Second People's Hospital" with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Southern Medical University" are "Beta Thalassemia" (3 trials), "Cervical Cancer" (2 trials), "Chronic Hepatitis b" (2 trials), "Colorectal Cancer" (2 trials) and "Sepsis" (2 trials). Many other conditions were trialed in "Southern Medical University" in a lesser frequency.

Most popular intervention types in "Southern Medical University" are "Drug" (19 trials), "Biological" (5 trials), "Diagnostic Test" (3 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Placebo" (2 trials), "QL-007" (2 trials), "TAS-102" (2 trials) and "TDF tablet" (2 trials). Other intervention names were less common.

The vast majority of trials in "Southern Medical University" are 29 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Southern Medical University". undefined are not yet recruiting, 15 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Southern Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southern Medical University, 6 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".